• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.23% Nasdaq Up 0.16%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    79.28 Down 0.52(0.65%) 1:08PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:79.80
    Open:80.00
    Bid:80.24 x 100
    Ask:80.48 x 100
    1y Target Est:95.50
    Beta:0.97
    Next Earnings Date:11-May-15LGND Earnings announcement
    Day's Range:79.28 - 82.06
    52wk Range:41.99 - 90.48
    Volume:167,458
    Avg Vol (3m):418,289
    Market Cap:1.55B
    P/E (ttm):141.57
    EPS (ttm):0.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LGND

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 0.65%1.55B
    LLYDown 0.12%77.46B
    MRKUp 1.62%172.05B
    RHHBYDown 0.25%N/A

    Key Statistics

    Forward P/E (1 yr):24.56
    P/S (ttm):24.21
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.13
    Quarterly EPS Est (Mar-15) :0.27
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):0.79

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback